Evidence map›Paper›PMID 31712709›Full record

ArticleScientific reports2019

Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy - a pilot study.

Elena Zaklyazminskaya, Vadim Mikhailov, Anna Bukaeva, Natalia Kotlukova, Inna Povolotskaya, Vladimir Kaimonov, Anna Dombrovskaya, Sergey Dzemeshkevich

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The genetic architecture of pediatric cardiomyopathy.American journal of human genetics · 2022
    Article
  9. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy.Journal of the American Heart Association · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Elena ZaklyazminskayaPetrovsky National Research Center of Surgery, 2, Abricosovsky side-street, 119991, Moscow, Russia.
Vadim MikhailovPetrovsky National Research Center of Surgery, 2, Abricosovsky side-street, 119991, Moscow, Russia. mihailov.vadim@gmail.com.
Anna BukaevaPetrovsky National Research Center of Surgery, 2, Abricosovsky side-street, 119991, Moscow, Russia.
Natalia KotlukovaPirogov Russian National Research Medical University, Moscow, Russia.
Inna PovolotskayaCentre of Genetics and Reproductive Medicine "Genetico", Moscow, Russian Federation.
Vladimir KaimonovCentre of Genetics and Reproductive Medicine "Genetico", Moscow, Russian Federation.
Anna DombrovskayaPetrovsky National Research Center of Surgery, 2, Abricosovsky side-street, 119991, Moscow, Russia.
Sergey DzemeshkevichPetrovsky National Research Center of Surgery, 2, Abricosovsky side-street, 119991, Moscow, Russia.
Russian Scientific Center of Surgery · RUResearch Centre for Medical Genetics · RUCity Clinical Hospital · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10-30% of the cases. The studies were mainly focused on the adult or mixed age group of patients with DCM. The mutation rate in the TTN gene, the characteristics of manifestations and their prognostic significance in childhood have not been studied. To determine TTN mutation rate in children with DCM and the relevance of including this gene in the DNA diagnostic protocol for paediatric DCM, complete clinical and instrumental examination of 36 DCM patients (up to 18 years) with the manifestation of the disease was conducted in specialised cardiology centres. Molecular genetic testing included sequencing of coding and adjacent regulatory regions of the major cardiac TTN isoform N2BA using IonTorrent ™ semiconductor sequencing (for 25 isolated cases) and trio whole exome sequencing (trio WES)on the Illumina platform (for 11 family cases). Our pilot group included 36 probands with DCM diagnosis first established on the basis of the generally accepted criteria at the age of 5 days to 18 years(average age: 6.5 years). The sex ratio (M:F) was 23: 8. There were 25 sporadic DCM cases and 11 cases of familial DCM (at least one of the parents and/or siblings were also diagnosed with DCM). The only likely pathogenic truncating variant p.Arg33703*in the TTN gene (TTNtv) was found in a 16-year-oldmale proband out of 36 (3%). Apparently, TTN-dependent forms of DCMs manifest later at a young (but older than 18 years) or more mature age, and TTN gene cannot be considered as the first-line genetic testing for DCM in the paediatric group, despite several studies have reported a generally high mutation rate in this gene with DCM. Further research is needed to compare the representation of mutations in the TTN gene in different age groups of DCM patients.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationAdolescentAllelesAmino Acid SubstitutionCardiomyopathy, DilatedChildChild, PreschoolConnectinFemaleGenotypeHumansInfantInfant, NewbornMaleConnectinTTN protein, human

Identifiers

PMID31712709
PMCPMC6848193
OpenAlexW2985374535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.